It’s What’s True - Benjam in L. Sievers - Narrative Perspective on Thyroid Cancer Treatment Decisions

Sep 24, 2026

Uploaded by nayy☆

Personal narrative of a young patient who develops papillary thyroid carcinoma after initially believing in good health, describing diagnosis, surgery, and post-operative findings including node involvement and ALK fusion. The text focuses on uncertainty around radioactive iodine dosing, contrasting perspectives from clinicians and international experts, noting increasing risks at higher doses and the lack of randomized trial evidence. The author ultimately chooses a 100 mCi treatment plan to balance efficacy and potential harm, reflecting on “what’s true.”

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages2

Reading Time5 min

AccessFree to download

Diagnosis and initial shock

Surgery and pathology findings

ALK fusion and prognosis context

Radiation oncology consultation and uncertainty

Searching for evidence and choosing a dose

It’s What’s True Benjamin L. Sievers1, Infectious Diseases, J. Craig Venter Institute, La Jolla, CA, USA 1Corresponding author: Benjamin L. Sievers, Infectious Diseases, J. Craig Venter Institute, La Jolla, CA 92037, USA. Email: [bsievers@JCVI.org](bsievers@JCVI.org) “It’s what’s true,” I remember my oncologist father’s words when an unusually friendly nuclear medicine technologist wearing a beanie with flaps above his ears enters my room, wheeling a cart holding a large lead pig.“Ben, can you spell for me your last name and give me your date of birth, please?” I had believed myself to be a healthy 22-year-old student graduating from college, studying to take the MCAT, and planning my Fulbright research fellowship in Phnom Penh. Now, I have thyroid cancer. I first knew something was wrong when a long strap muscle in my neck snapped over an enlarged lymph node just above my clavicle as I turned my head to merge lanes. A week later, my new surgeon gently plunged a needle into my neck as I stared at various shades of gray on an ultrasound screen. I remained utterly still as we all visualized the needle tip on the screen, and I was scared. At the same time, I felt considerable resolve. My tumor cells smeared on a microscope slide would illuminate truth and define next steps. Together, we’d learn“what’s true.” Papillary thyroid carcinoma was confirmed from the needle aspiration procedure and a spontaneous cancellation offered an auspicious opening in my surgeon’s busy schedule, enabling me to have my cancer procedure that same week. My concerned parents seemed pleased to move quickly. Me? A bit more reluctant. Although looking back, I now don’t regret missing weeks of anxious anticipation. The night before my procedure, my family and I shared a quick meal and tried to cultivate some humor and a bit of perspective.“My surgeon said I had stage I disease because I’m young. I guess that’s a plus, right?” My family’s heads nodded affirmatively. Upon awakening the next morning, curiosity and more resolve were what I felt in the 5 AM quiet darkness of the preoperative waiting room as I waited for me to be summoned.“Let’s do this.” I experienced exceptional kindness from everyone I met that morning. My IV was placed with competent flourish and an easy humor seemed to flow among the OR nurses. I appreciated this greatly. I later learned that my family walked loopsin the hospital parking lot for the four hours as I received a complete thyroidectomy and modified radical neck dissection. While I don’t remember much immediately post-op, I awakened with thick plastic tubes in my neck that moved when I swallowed or spoke. Almost immediately, I was desperate to get mine out. Gratefully, in my post-op clinic with a gentle tug from my surgeon, my tubes slid out like tired snakes. Now, an “epic” scar traces from just under my ear to the middle of my throat. And now, my formal diagnosis of follicular variant papillary thyroid carcinoma was established with 6 of 38 nodes infiltrated by cancer. The pathologist noted “tall cells” that are believed to be somewhat less likely to take up radioactive iodine. I underwent staging and I also have three sub centimeter nodules in my lungs of “unclear significance.” Call these metastases, and that’s not good, but call them post-infectious granulomas, and that’s sweet reassurance. Next-generation sequencing of my tumor identified an ALK fusion gene. Reading more, I learned that not much was known about its significance in thyroid cancer, although there were case reports suggesting an association with more aggressive disease. At the same time, ALK inhibitors in clinical trials were anecdotally revealing promising outcomes. Here we were again: reasonably good news mixed with challenging news. Ultimately, my physicians celebrate my youth because it’s associated with a good overall prognosis, despite my cancer’s high-risk features. That’s also “what’s true.” I then met in consultation with a radia

FAQs

How did the patient first realize something was wrong?

They noticed a neck strap muscle snap over an enlarged lymph node while turning their head, followed by ultrasound findings and a needle procedure.

What key results shaped the diagnosis and risk assessment?

Papillary thyroid carcinoma was confirmed, with 6 of 38 nodes infiltrated, and additional lung nodules of unclear significance; tumor sequencing identified an ALK fusion gene.

Why was radioactive iodine dosing a difficult decision?

The recommended dose was not based on randomized trials, and higher doses increased risks such as secondary malignancy and salivary gland damage, while experts and local teams differed on the best approach.

Sep 24, 2026

Uploaded by nayy☆